Abstract
Recently two tetrapeptide ligands that bind preferentially to the μ- opioid receptor were identified and named endomorphin-1 and endomorphin-2. We examined the ability of these peptides to stimulate G protein activation in human μ-opioid receptor transfected B82 fibroblasts as measured by [35S]GTPγS binding to cell membranes. Both endomorphin-1 and -2 act as partial agonists in this assay system compared with the μ-selective agonist [D-Ala2,N-Me-Phe4, Gly-ol5]enkephalin (DAMGO). In addition, endomorphins demonstrate efficacy similar to morphine. These findings demonstrate that endomorphin peptides have similar activity at the μ-opioid receptor as morphine and suggest that these peptides have the potential to modulate neuronal activity in vivo.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 111-114 |
| Number of pages | 4 |
| Journal | European Journal of Pharmacology |
| Volume | 346 |
| Issue number | 1 |
| DOIs | |
| State | Published - Apr 3 1998 |
| Externally published | Yes |
Keywords
- Efficacy
- Endomorphin-1
- Endomorphin-2
- μ-Opioid receptor
ASJC Scopus subject areas
- Pharmacology
Fingerprint
Dive into the research topics of 'Endomorphin-1 and endomorphin-2 are partial agonists at the human μ- opioid receptor'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS